Evidence map›Paper›PMID 36970400›Full record

ArticleFrontiers in chemistry2023

DUS evaluation of nine intersubgeneric hybrids of

Shiyi Xu, Weili Liu, Xiubo Liu, Chen Qin, Lianqing He, Panpan Wang, Lingyang Kong, Xi Chen, Zhiyang Liu, Wei Ma

Open access · goldFull text read
In one paragraph

Article in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shiyi XuSchool of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Weili LiuSchool of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Xiubo LiuSchool of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Chen QinSchool of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Lianqing HeSchool of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Panpan WangSchool of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Lingyang KongSchool of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Xi ChenHarbin Academy of Agricultural Sciences, Harbin, China.
Zhiyang LiuHarbin Academy of Agricultural Sciences, Harbin, China.
Wei MaSchool of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Heilongjiang University of Chinese Medicine · CNAcademic Degrees & Graduate Education · CNHeilongjiang Provincial Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intersubgeneric hybrids of

Indexed as

DUSfingerprint analysisHPLCintersubgeneric hybridPaeonia lactiflora pall.paeoniflorinstoichiometric analysis

Identifiers

PMID36970400
PMCPMC10038168
OpenAlexW4323865366

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read80
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.